161 related articles for article (PubMed ID: 57505)
21. Bone aluminum and histomorphometric features of renal osteodystrophy.
Hodsman AB; Sherrard DJ; Alfrey AC; Ott S; Brickman AS; Miller NL; Maloney NA; Coburn JW
J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841
[TBL] [Abstract][Full Text] [Related]
22. Renal osteodystrophy in course of periodic dialysis for chronic uremia.
Kim D; Bell NH; Bundesen W; Putong P; Simon NM; Walker C; Del Greco F
Trans Am Soc Artif Intern Organs; 1968; 14():367-71. PubMed ID: 5701557
[No Abstract] [Full Text] [Related]
23. Long-term experience of alfacalcidol in renal osteodystrophy.
Sharman VL; Brownjohn AM; Goodwin FJ; Hately W; Manning RM; O'Riordan JH; Papapoulos SE; Marsh FP
Q J Med; 1982; 51(203):271-8. PubMed ID: 7146311
[TBL] [Abstract][Full Text] [Related]
24. Dialysis osteodystrophy. A study involving 94 patients.
Chan YL; Furlong TJ; Cornish CJ; Posen S
Medicine (Baltimore); 1985 Sep; 64(5):296-309. PubMed ID: 3839891
[TBL] [Abstract][Full Text] [Related]
25. Serum alkaline phosphatase in azotemic and hemodialysis osteodystrophy: a study of isoenzyme patterns, their correlation with bone histology, and their changes in response to treatment with 1alphaOHD3 and 1,25(OH)2D3.
Pierides AM; Skillen AW; Ellis HA
J Lab Clin Med; 1979 Jun; 93(6):899-909. PubMed ID: 438610
[TBL] [Abstract][Full Text] [Related]
26. [Application of bone densitometry for detection of renal osteodystrophy in patients on maintenance haemodialysis].
Tomanoski V
Srp Arh Celok Lek; 1994; 122(1-2):10-3. PubMed ID: 17972792
[TBL] [Abstract][Full Text] [Related]
27. Calcium metabolism in renal failure.
David DS
Am J Med; 1975 Jan; 58(1):48-56. PubMed ID: 1090150
[TBL] [Abstract][Full Text] [Related]
28. Iliac bone marrow mast cells in relation to the renal osteodystrophy of patients treated by haemodialysis.
Ellis HA; Peart KM
J Clin Pathol; 1976 Jun; 29(6):502-16. PubMed ID: 939806
[TBL] [Abstract][Full Text] [Related]
29. Hypophosphataemic osteomalacia in patients receiving haemodialysis.
Mahony JF; Hayes JM; Ingham JP; Posen S
Br Med J; 1976 Jul; 2(6028):142-4. PubMed ID: 1276833
[TBL] [Abstract][Full Text] [Related]
30. Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysis.
de Fremont JF; Sebert JL; Gueris J; Marie P; Coevoet B; Makdassi R; Lambrey G; Meunier P; Fournier A
Proc Eur Dial Transplant Assoc; 1979; 16():675-6. PubMed ID: 232918
[No Abstract] [Full Text] [Related]
31. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
Voigts AL; Felsenfeld AJ; Llach F
Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
[TBL] [Abstract][Full Text] [Related]
32. 1alpha-hydroxycholecalciferol. Long-term treatment of patients with uraemic osteodystrophy.
Nielsen SP; Binderup E; Godtfredsen WO; Jensen H; Ladefoged J
Nephron; 1976; 16(5):359-70. PubMed ID: 1264309
[TBL] [Abstract][Full Text] [Related]
33. 1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy.
Brickman AS; Sherrard DJ; Jowsey J; Singer FR; Baylink DJ; Maloney N; Massry SG; Norman AW; Coburn JW
Arch Intern Med; 1974 Nov; 134(5):883-8. PubMed ID: 4613310
[No Abstract] [Full Text] [Related]
34. Treatment of renal bone disease.
Lancet; 1979 Dec 22-29; 2(8156-8157):1339-40. PubMed ID: 92678
[No Abstract] [Full Text] [Related]
35. Renal bone disease.
Llach F
Transplant Proc; 1991 Apr; 23(2):1818-22. PubMed ID: 2053165
[No Abstract] [Full Text] [Related]
36. Azotaemic renal osteodystrophy: a quantitative study on iliac bone.
Ellis HA; Peart KM
J Clin Pathol; 1973 Feb; 26(2):83-101. PubMed ID: 4696838
[TBL] [Abstract][Full Text] [Related]
37. Calcifediol in chronic renal insufficiency. Skeletal response.
Teitelbaum SL; Bone JM; Stein PM; Gilden JJ; Bates M; Boisseau VC; Avioli LV
JAMA; 1976 Jan; 235(2):164-7. PubMed ID: 946022
[TBL] [Abstract][Full Text] [Related]
38. Hemodialysis patients with a unique mineralizing defect unresponsive to 1,25-dihydroxycholecalciferol. Dialysis osteomalacic syndrome.
Cameron EC; Prior JC; Ballon HS
Contrib Nephrol; 1980; 18():162-71. PubMed ID: 6986229
[TBL] [Abstract][Full Text] [Related]
39. Phosphate-deficiency osteomalacia during regular haemodialysis.
Pierides AM; Ellis HA; Kerr DN
Lancet; 1976 Oct; 2(7988):746. PubMed ID: 61429
[No Abstract] [Full Text] [Related]
40. Iatrogenic osteomalacia and myopathy due to phosphate depletion.
Baker LR; Ackrill P; Cattell WR; Stamp TC; Watson L
Br Med J; 1974 Jul; 3(5924):150-2. PubMed ID: 4843652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
